Franklin Pass

Part of Halozyme Therapeutics, Inc., Permatec Holding AG develops novel transdermal and buccal drug delivery systems. The company is based in Allschwil, Switzerland. The Swiss company was founded by Jacques Gonella. Permatec Holding was acquired by Antares Pharma, Inc., part of Halozyme Therapeutics, Inc. from May 25, 2022 on February 01, 2000.

Performance Health Technologies, Inc. develops and markets performance evaluation and rehabilitation products that monitor and guide exercise and give real-time motivational feedback. The company's products provide varied exercise modes and assessment tools. Its clinical products allow clinicians to print reports for record keeping and compliance. Performance Health Technologies was founded in 1998 and is headquartered in Trenton, NJ.

Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York.

Part of Halozyme Therapeutics, Inc., Antares Pharma AG manufactures and develops gel and patch technologies for use in hormone replacement therapy. Antares Pharma was acquired by Antares Pharma, Inc., a subsidiary of Halozyme Therapeutics, Inc. from Permatec Holding AG on February 01, 2001 for $13.23 million.

Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN.

American Biosystems, Inc. specializes in the production of enzymes and direct-fed microbial. The firm offers acquaculture system treatment, direct-fed microbials, enzymes, industrial cleaning and waste-water treatment services. The company was founded in 1988 and is headquartered in Roanoke, VA.

Advanced Respiratory Technologies, Inc. develops medical devices for the treatment of chronic respiratory diseases. The company is based in Land O Lakes, FL. The company was founded by Steven Kessler, Darren A. Rubin.

Laboratorios Beta SA is an Argentinean pharmaceutical company that specializes in the manufacturing and wholesale of anti-inflammatory and anti-rheumatic drugs. The private company is based in Buenos Aires, Argentina.

APR Applied Pharma Research SA develops and licenses healthcare products and technologies. It specializes in the development of oral and topical formulations in various healthcare regulatory areas ranging from Rx and OTC pharmaceuticals, nutraceuticals, dermocosmetics, and medical devices. The company was founded in 1990 and is headquartered in Balerna, Switzerland.

Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier.

Amzell Ltd. is a Dutch virtual development pharmaceutical company that specializes in taking candidate or repurposed drugs and devices through to proof of concept or registration for sale to commercial healthcare companies. The private company is based in Hoofddorp, Netherlands, and has subsidiaries in Switzerland. The company focuses on developing well-characterized active substances using innovative platform drug delivery technologies to provide more effective drug delivery, increased efficacy, and improved safety and compliance. One of their products, AMZ001, is a non-invasive topical gel formulation containing 3.06%% diclofenac sodium, which is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain related to knee osteoarthritis. The CEO of the company is Dario N. R. Carrara.